Baker Daniel G. 4
4 · Cue Biopharma, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Baker Daniel G.
CHIEF DEVELOPMENT OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-09-29+50,000→ 50,000 totalExercise: $0.72Exp: 2035-09-28→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option becomes fully exercisable on the first anniversary of the grant date.